Matt Larew
Stock Analyst at William Blair
(2.46)
# 2,870
Out of 4,396 analysts
179
Total ratings
44.3%
Success rate
1.2%
Average return
Main Sectors:
Stocks Rated by Matt Larew
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintained: Buy | n/a | $21.11 | - | 12 | Jun 1, 2026 | |
| TWST Twist Bioscience | Reiterated: Buy | n/a | $70.06 | - | 10 | May 26, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | n/a | $494.07 | - | 9 | May 21, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | n/a | $334.66 | - | 11 | May 20, 2026 | |
| RGEN Repligen | Maintained: Buy | n/a | $130.13 | - | 9 | May 14, 2026 | |
| MXCT MaxCyte | Maintained: Hold | n/a | $1.19 | - | 9 | May 13, 2026 | |
| DNA Ginkgo Bioworks Holdings | Reiterated: Sell | n/a | $8.25 | - | 12 | May 11, 2026 | |
| TXG 10x Genomics | Maintained: Buy | n/a | $30.59 | - | 9 | May 8, 2026 | |
| MRVI Maravai LifeSciences Holdings | Maintained: Hold | n/a | $5.10 | - | 13 | May 8, 2026 | |
| TECH Bio-Techne | Maintained: Buy | n/a | $54.41 | - | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.46 | - | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $18.10 | - | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.99 | - | 13 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $371.15 | - | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $119 | $115.90 | +2.67% | 12 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.91 | - | 8 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $188.41 | - | 8 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $189.85 | - | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $61.80 | n/a | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.60 | n/a | 1 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.69 | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $198.19 | n/a | 4 | Sep 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $271.24 | n/a | 1 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $104.19 | n/a | 1 | Nov 21, 2017 |
Option Care Health
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $21.11
Upside: -
Twist Bioscience
May 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $70.06
Upside: -
Thermo Fisher Scientific
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $494.07
Upside: -
West Pharmaceutical Services
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $334.66
Upside: -
Repligen
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $130.13
Upside: -
MaxCyte
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $1.19
Upside: -
Ginkgo Bioworks Holdings
May 11, 2026
Reiterated: Sell
Price Target: n/a
Current: $8.25
Upside: -
10x Genomics
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $30.59
Upside: -
Maravai LifeSciences Holdings
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $5.10
Upside: -
Bio-Techne
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $54.41
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $4.46
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $18.10
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.99
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $371.15
Upside: -
May 1, 2026
Rated: Hold
Price Target: $119
Current: $115.90
Upside: +2.67%
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $9.91
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $188.41
Upside: -
Oct 11, 2025
Upgraded: Buy
Price Target: n/a
Current: $189.85
Upside: -
Oct 8, 2024
Reiterated: Hold
Price Target: n/a
Current: $61.80
Upside: n/a
Aug 22, 2022
Maintained: Buy
Price Target: n/a
Current: $20.60
Upside: n/a
Sep 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $7.69
Upside: n/a
Sep 11, 2019
Downgraded: Hold
Price Target: n/a
Current: $198.19
Upside: n/a
Dec 3, 2018
Maintained: Buy
Price Target: n/a
Current: $271.24
Upside: n/a
Nov 21, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $104.19
Upside: n/a